Top1000 Scholar

Scholarly Index

Primo N. Lara

University of California, Davis; 24,491 total citations; 646 total publications; best world rank #75

University of California, Davis

24,491Total citations
646Total publications
72H-index

Published ranking records

FieldWindowWorld rankNational rankImpact score
Lung Cancer Treatments and MutationsLifetime288US 15299.26
Renal cell carcinoma treatmentLifetime180US 10999.03
Lung Cancer Research StudiesLifetime208US 10399.11
Peptidase Inhibition and AnalysisLifetime378US 17998.54
Cancer Genomics and DiagnosticsLifetime648US 35498.81
Prostate Cancer Treatment and ResearchLifetime365US 20998.92
Cancer therapeutics and mechanismsLifetime300US 17998.33
Renal and related cancersLifetime449US 22697.88
Lung Cancer Diagnosis and TreatmentLifetime899US 39397.81
Multiple Myeloma Research and TreatmentsLifetime567US 25997.20
Bladder and Urothelial Cancer TreatmentsLifetime755US 32997.27
Radiopharmaceutical Chemistry and ApplicationsLifetime998US 38995.96
PI3K/AKT/mTOR signaling in cancerLifetime784US 42494.44
Multiple and Secondary Primary CancersLifetime700US 29793.63
Economic and Financial Impacts of CancerLifetime750US 47593.08
PARP inhibition in cancer therapyLifetime915US 38391.27
Renal cell carcinoma treatment2021-2025108US 4598.04
Renal and related cancers2021-202575US 3897.40
Prostate Cancer Treatment and Research2021-2025469US 17595.78
Bladder and Urothelial Cancer Treatments2021-2025940US 25990.21
Radiopharmaceutical Chemistry and Applications2021-2025773US 18987.50
PARP inhibition in cancer therapy2021-2025701US 25982.70
Multiple and Secondary Primary Cancers2021-2025485US 17676.82